BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2018
View Archived Issues
Sanofi and Revolution Medicines collaborate to develop targeted therapies for multiple cancers
Read More
KH-NDTC, novel orally active inverse agonist of ERR-gamma as enhancer for sodium iodide symporter
Read More
NT-1654 reduces clinical severity of EAMG in rats
Read More
Pilot study to identify novel biomarkers of endometrial cancer and its recurrence following surgery
Read More
Novel human T regulatory-selective IL-2 antibody for autoimmune or graft-versus-host diseases
Read More
H4:IC31 or BCG vaccination reduces the rate of sustained M. tuberculosis infection in phase II trial
Read More
Leukemia cells hitch ride to brain via bone and blood
Read More
Synaptic vesicle glycoprotein 2A by PET imaging, a marker of synaptic density in Alzheimer's disease
Read More
FDA places partial clinical hold on phase I study of XMT-1522
Read More
Toray cleared to begin phase I study of TRK-250 in patients with idiopathic pulmonary fibrosis
Read More
Kite and Gadeta to develop novel gamma delta TCR therapies
Read More
Mutations in MYF5 gene found to cause ophthalmoplegia with rib and vertebral anomalies
Read More
Alligator seeks clearance for phase I study of ATOR-1015
Read More
PureTech and Roche collaborate on technology for oral administration of antisense oligonucleotides
Read More
Day 150 topline results from phase I/II study of THR-317 in DME confirm safety and tolerability
Read More
Institute of Materia Medica of Beijing patents PI3Kalpha inhibitors
Read More
Merck & Co. presents HIV-1 protease inhibitors
Read More
Glenmark Pharmaceuticals discloses new RORC antagonists
Read More
BioMarin Pharmaceutical divulges CGT inhibitors
Read More
Epizyme discovers EHMT1 and/or EHMT2 inhibitors
Read More
